BIOVIE INC.
BIOVIE INC. (BIVI): 2 pipeline candidates · 1 upcoming catalyst · ~6 mo cash runway · 2 clinical trials. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
5.7 months
D/E 0.12 · 0% dilution
Lead: Phase 3
2 candidates
1 upcoming, next in ~104d
N/A
A transparent, data-derived signal for BIOVIE INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$12.4M
Cash
$13.1M
Quarterly Burn
$7.4M
Runway
5.7 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (2 candidates)
| Drug | Phase |
|---|---|
| bezisterim (NE3107) | Phase 3 |
| NE3107 | Phase 2 |
Upcoming Catalysts (1)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
33
Total value held
$1.4M
| Holder | Shares | Value |
|---|---|---|
| diametric capital, lp | 370,000 | $518K |
| vanguard capital management llc | 168,134 | $235K |
| prelude capital management, llc | 92,063 | $129K |
| geode capital management, llc | 84,203 | $118K |
| morgan stanley | 75,221 | $105K |
| renaissance technologies llc | 67,918 | $95K |
| citadel advisors llc | 45,292 | $63K |
| vanguard fiduciary trust co | 37,557 | $53K |
| jane street group, llc | 22,791 | $32K |
| xtx topco ltd | 21,226 | $30K |
Showing top 10 of 33 institutional holders of BIOVIE INC.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in BIOVIE INC.'s pipeline?
BIOVIE INC. (BIVI) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is BIOVIE INC.'s lead drug candidate?
BIOVIE INC.'s most advanced tracked candidate is bezisterim (NE3107) (Phase 3) for Long COVID.
What is BIOVIE INC.'s next catalyst?
BIOVIE INC.'s next tracked catalyst is a Phase2_Topline event — "Phase 2 Readout: bezisterim" — expected September 30, 2026.
What is BIOVIE INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, BIOVIE INC. has approximately 5.7 months of cash runway.
What is BIOVIE INC.'s market capitalization?
BIOVIE INC.'s market capitalization is approximately $12.4M.
Get the full picture on BIOVIE INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.